SCHEMBL807407

SCHEMBL807407

CCC(OC)C(=O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8520065 1.00
SCHEMBL25600153 1.00
Trifluoroacetic Acid SCHEMBL5319837 0.85 CA1 (0.40)
SCHEMBL15726596 0.84 CA1 (0.38)
SCHEMBL4430069 0.84 CA1 (0.45)
SCHEMBL12951611 0.82 ALDH1A1 (0.43)
SCHEMBL807405 0.82 ALDH1A1 (0.43)
SCHEMBL6385908 0.81 CA1 (0.39)
SCHEMBL882111 0.80
SCHEMBL12072072 0.80 CA1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102372674-A Synthesis method for pharmaceutical intermediate 3-formyl-4-halogeno pyrazole WUXI APPTEC CO LTD 2012-03-14 CN claimed
EP-1304325-A1 5-(M-CYANOBENZYLAMINO)PYRAZOLE DERIVATIVES Sankyo Company, Limited (JP) 2003-04-23 EP claimed
JP-7228895-A None JP disclosed
US-20250177539-A1 ER DEGRADERS AND USES THEREOF ASTRAZENECA AB (SE) 2025-06-05 US disclosed
EP-4392420-A1 HPK1 DEGRADERS, COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME BIOFRONT LTD (KY) 2024-07-03 EP disclosed
CN-118267729-A System for producing 4-chlorobutyrate methyl ester by thionyl chloride method and control method 江西世龙实业股份有限公司 2024-07-02 CN disclosed
CN-117908324-A Negative photosensitive resin composition for high refractive index patterning 罗门哈斯电子材料韩国有限公司 2024-04-19 CN disclosed
CN-111868051-B Aminopyrimidine derivatives as CTPS1 inhibitors 斯泰普制药股份公司 2024-04-09 CN disclosed
CN-117343049-A Rho-related protein kinase inhibitor, pharmaceutical composition containing Rho-related protein kinase inhibitor, and preparation method and application of Rho-related protein kinase inhibitor 北京泰德制药股份有限公司 2024-01-05 CN disclosed
CN-110582489-B Rho-related protein kinase inhibitor, pharmaceutical composition containing Rho-related protein kinase inhibitor, and preparation method and application of Rho-related protein kinase inhibitor 北京泰德制药股份有限公司 2023-10-27 CN disclosed
US-20230125751-A1 METHODS AND COMPOUNDS FOR TREATING PARAMYXOVIRIDAE VIRUS INFECTIONS GILEAD SCIENCES, INC. 2023-04-27 US disclosed
CN-1717625-A Template INGENIA TECHNOLOGY LTD (VG) 2006-01-04 CN disclosed
US-20040181094-A1 Transition metal oxo complexes as catalysts of synthetic processes involving alkyne reactants REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE 2004-09-16 US disclosed
EP-1304325-A1 5-(M-CYANOBENZYLAMINO)PYRAZOLE DERIVATIVES Sankyo Company, Limited (JP) 2003-04-23 EP disclosed
CN-1290249-A Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2001-04-04 CN disclosed
EP-0379691-B2 Process for preparing unsaturated carboxylic acid or ester thereof MITSUBISHI GAS CHEMICAL CO (JP) 2001-01-03 EP disclosed
JP-H07228895-A SOLVENT COMPOSITION NITTO CHEM IND CO LTD 1995-08-29 JP disclosed
US-5250729-A Process for preparing unsaturated carboxylic acid or ester thereof MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1993-10-05 US disclosed
US-4520209-A Process for cyclizing upsilon-chlorocarboxylic acids DEGUSSA AKTIENGESELLSCHAFT (DE) 1985-05-28 US disclosed
US-4156785-A FROM AN UNSATURATED HALOGEN COMPOUND, CARBON MONOXIDE AND AN ALKALI METAL ALCOHOLATE USING NICKEL OR COBALT CARBONYL AS CATALYST DYNAMIT NOBEL AKTIENGESELLSCHAFT (DE) 1979-05-29 US disclosed